Medical research & trials
Medical research & trials · 14 stories in 12h · Clear all filters
- Nasdaq.com Edesa Biotech, Inc. Announces EU Orphan Designation for ParidiprubartOn November 17, 2026, Edesa Biotech, Inc. (the “Company”) announced that the European Commission has granted orphan designation…
- Nasdaq.com Purple Biotech Reports Third Quarter 2026 Financial Results and Provides Business UpdatePurple Biotech Ltd. reported its financial results for the three months ended September 30, 2026, and provided an…
-
Europe has recognised the nutritional gap in cancer care. Now action must follow. [Promoted Content]Up to seven in ten people with cancer face malnutrition, yet only one in five is assessed for…
-
Mahama to unveil new DNA, vaccine research laboratories at NoguchiPresident John Dramani Mahama is expected to commission new human DNA testing laboratories and a dedicated vaccine development…
- Nasdaq.com Adagene and City of Hope Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal CancerAdagene Inc. and City of Hope have announced the launch of an investigator-initiated Phase 1 clinical trial to…
-
Kannada Comprehensive Medical Literature Conference-2026 to be held on November 20 and 21RGUHS has received a good response and over 1,900 people have registered to participate in the festival, which…
-
VolitionRx reports clinical progress across diagnostic platform
-
Regeneron at Jefferies conference: growth, patents and pipeline
-
Ireland drops cross-border trials language from Biotech Act draftEU countries split over how to help patients join trials abroad…
-
Kernal Bio secures funding from IFLI for lymphoma treatment
-
Tamil Nadu Health Minister Arunraj inaugurates Centre for Advanced Genomics at Ranipet CMCHealth officials said that the new facility is aimed to provide high-end genetic testing and will enable rapid…
-
Valion Bio completes 200-liter Entolimod production run
-
Protagonist Therapeutics at Jefferies Global Healthcare Conference: partner-led growth
- Investing.com EyePoint at UBS biopharma conference: DME hopes offset wet AMD setback
8 more stories in other languages (Portuguese 4, Spanish 3, German 1) ·